In particular, in neurodegenerative diseases, a decrease in HIF-1a levels is observed, which is associated with the increased phosphorylation of tau protein and the formation of neurofilaments in Alzheimer’s disease, and the introduction of HIF-1 has a protective effect [154]. This evidence concerns the gene HIF1A and early-onset autosomal dominant Alzheimer disease.